title: Anti-carcinogenic effects of the phenolic-rich extract from abnormal Savda Munziq in association with its cytotoxicity, apoptosis-inducing properties and telomerase activity in human cervical cancer cells (SiHa).
abstract: BACKGROUND
  Abnormal Savda Munziq (ASMq) is a herbal preparation used in Traditional Uighur Medicine for the treatment cancer. The polyphenol is main compounds contained in ASMq preparation responsible for anticancer effect of ASMq.
  
  
  METHODS
  In this study,Real-time quantitative Polymerase Chain Reaction (RT-PCR) assay, MTT assay and flow cytometry were used to investigate the effect of polyphenol of ASMq on cell viability and the potential of the phenolic rich extracts of ASMq to induce apoptosis in human cervical cancer cells SiHa and its effects on telomerase activity were investigated. Cellular morphological change was observed by phase contrast microscopy. The MTT cell viability data revealed that treatment with phenolic rich extracts at 75 ~ 175 μg/ml significantly inhibited the viability and proliferation of cells, and these effects occurred in a concentration-dependent manner and time dependent manner (P < 0.01).
  
  
  RESULTS
  The phenolic rich extracts can induce apoptosis of SiHa cells, can increase the apoptosis rate in a concentration-dependent manner and time dependent manner (P < 0.01). Growth inhibition and apoptosis induction by phenolic rich extracts treatment on SiHa cells was associated with down-regulation of anti-apoptotic Bcl-2 expression and telomerase (P < 0.05) and Survivin expression. In addition, phenolic rich extracts exerted a dose-dependent induction of FHIT expression.
  
  
  CONCLUSIONS
  These results suggest that phenolic rich extracts may have anti-tumor effects in human cervical cancer through cytotoxicity, apoptosis-inducing properties and telomerase activity.
authors.affiliation: Fifth Department of Gynecology, Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, 830011, China. gzlnr@qq.com.
authors.forename: Guzalnur
authors.initials: G
authors.lastname: Abliz
authors.affiliation: Fifth Department of Gynecology, Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, 830011, China. fatimaxir@hotmail.com.
authors.forename: Fatima
authors.initials: F
authors.lastname: Mijit
authors.affiliation: Fifth Department of Gynecology, Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, 830011, China. 40411629@qq.com.
authors.forename: Li
authors.initials: L
authors.lastname: Hua
authors.affiliation: Fifth Department of Gynecology, Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, 830011, China. guzalnur1112@126.com.
authors.forename: Guzalnur
authors.initials: G
authors.lastname: Abdixkur
authors.affiliation: Fifth Department of Gynecology, Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, 830011, China. 14026546@qq.com.
authors.forename: Tangnur
authors.initials: T
authors.lastname: Ablimit
authors.affiliation: Traditional Uighur Medicine Institute, Xinjiang Medical University, 393 Medical University Road, Urumqi, Xinjiang, 830011, PR China. nur818@hotmail.com.
authors.forename: Nurmuhammat
authors.initials: N
authors.lastname: Amat
authors.affiliation: Traditional Uighur Medicine Institute, Xinjiang Medical University, 393 Medical University Road, Urumqi, Xinjiang, 830011, PR China. halmurat@263.net.
authors.forename: Halmurat
authors.initials: H
authors.lastname: Upur
mesh_terms: D017766:Acid Anhydride Hydrolases / Q000378:metabolism; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D015536:Down-Regulation / Q000187:drug effects; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000378:metabolism; D008519:Medicine, Traditional; D009363:Neoplasm Proteins / Q000378:metabolism; D010636:Phenols / Q000494:pharmacology / Q000627:therapeutic use; D008517:Phytotherapy; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D059808:Polyphenols / Q000494:pharmacology / Q000627:therapeutic use*; D000077022:Survivin; D019098:Telomerase / Q000378:metabolism*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D000099170:Bis(5'-adenosyl)triphosphatase
chemical_list: D017766:Acid Anhydride Hydrolases; D016588:Anticarcinogenic Agents; D000972:Antineoplastic Agents, Phytogenic; D051034:Inhibitor of Apoptosis Proteins; D009363:Neoplasm Proteins; D010636:Phenols; D010936:Plant Extracts; D059808:Polyphenols; D000077022:Survivin; D019098:Telomerase; D000099170:Bis(5'-adenosyl)triphosphatase; C107489:BIRC5 protein, human